Lorcaserin or Lorqess: Analysis of FDA Panel

Lorcaserin or Lorqess: Analysis of FDA Panel

This is an analysis of Lorcaserin or Lorqess and the upcoming FDA advisory panel.  If curious or have any questions or want more such analysis, please email dg_writing@hotmail.com – thanks! Lorcaserin or Lorqess is going up for an FDA advisory panel on September 16,...
Analysis: Probability of Acthar Approval

Analysis: Probability of Acthar Approval

This is selected excerpts from an analysis Health and Life published for the pharmaceutical industry.  If interested in receiving similar reports for future drug approvals, email dg_writing@hotmail.com  Thank you. Who: Questcor (QCOR: $10.02) is a small pharmaceutical...
Obesity Drugs 2010, Which Is the Best?

Obesity Drugs 2010, Which Is the Best?

Three weight-loss pills are going up for FDA approval this year, 2010 – Qnexa, lorcaserin, and Contrave.  Here we present the state of the field for weight-loss pills and analyze each treatment. Currently, there are not that many treatments for obesity right now in...